Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-21

Clinical Trial Update: Combined Fractional CO2 Laser With Topical Tioconazole Versus Q-switched Nd:YAG Laser in the Treatment of Onychomycosis; a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing combined fractional CO2 laser with topical tioconazole versus Q-switched Nd:YAG laser for treatment of onychomycosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Q-switched Nd:YAG laser
  • tioconazole (tioconazole)

Snippet

Sponsor: Cairo University | Conditions: Onychomycosis of Fingernail | Phase 4 | Status: UNKNOWN